The Aga Khan University (AKU) has been awarded a Ksh. 19.6 million research grants by the National Institutes of Health\u00a0to perform clinical testing of a low-cost handheld 3D medical imaging device for detecting cervical cancer\u00a0in Kenya.<\/p>\n
The grant is part of a two-year Ksh. 261 million grant\u00a0funded by the National Cancer Institute (NCI) which will be used to complete research and development and conduct clinical testing of the device\u00a0at AKU in\u00a0Kenya, the University of Science and Technology\u00a0in\u00a0Malawi and at Virginia Tech [VT] Carilion School of Medicine\u00a0in\u00a0the United States.<\/p>\n
Dr Elkanah Omenge, Chair, Department of Obstetrics and Gynaecology, AKU Medical College, East Africa and Co-Principal Investigator in the\u00a0grant said, \u201cI am excited with this grant, which will enable AKU to make significant strides in addressing the burden of cervical cancer in the country. Our goal is to play a role in the early detection, diagnosis, and treatment of cervical cancer patients which will help combat this preventable disease.\u201d<\/p>\n
According to the World Health Organisation (WHO), globally, cervical cancer is the fourth most common cancer in women, with around 660, 000 new cases in 2022. In the same year, about 94% of the 350,000 deaths caused by cervical cancer occurred in low- and middle-income countries. The highest rates of cervical cancer incidence and mortality are in the sub-Saharan Africa region. In Kenya, cervical cancer is the second most common cancer among Kenyan women after breast cancer but is the leading cause of cancer-related deaths among Kenyan women. The burden is disproportionately higher in less developed regions due to limited access to preventative measures such as human papillomavirus (HPV) vaccination programs and effective screening strategies.<\/p>\n
\u201cWe spent years in research and development, so we are now extremely excited to start clinical tests with patients in three countries. Being able to partner with health leaders at Aga Khan University has been an incredible opportunity for proving new life-saving technologies in the prevention of cervical cancer,\u201d said Dr Joe Carson, the Co-principal investigator on this grant and Pensievision\u2019s Chief Technology Officer.<\/p>\n
In Kenya, the study which is in partnership with Pensievision, Inc., an imaging technology startup, will start in September 2024 and will be implemented at Aga Khan University Hospital, Nairobi, the Hospital\u2019s outreach medical centers and at the community level.<\/p>\n
The post Aga Khan University receives Ksh. 19.6 million\u00a0research grant to advance cervical cancer testing in Kenya<\/a> first appeared on KBC<\/a>.<\/p>","protected":false},"excerpt":{"rendered":" The Aga Khan University (AKU) has been awarded a Ksh. 19.6 million research grants by the National Institutes of Health\u00a0to perform clinical testing of a low-cost handheld 3D medical imaging device for detecting cervical cancer\u00a0in Kenya. The grant is part of a two-year Ksh. 261 million grant\u00a0funded by the National Cancer Institute (NCI) which will […]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-28510","post","type-post","status-publish","format-standard","hentry","category-uncategorized","entry"],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/posts\/28510","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/comments?post=28510"}],"version-history":[{"count":0,"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/posts\/28510\/revisions"}],"wp:attachment":[{"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/media?parent=28510"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/categories?post=28510"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/chezaspin.com\/blog\/wp-json\/wp\/v2\/tags?post=28510"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}